- As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in cases where traditional antipsychotic medications and psychosocial interventions have been ineffective?
- What are the challenges and opportunities in utilizing biomarkers of inflammation to aid in the early diagnosis and personalized treatment of Alzheimer’s disease, and how can PMHNPs stay current with advancements in this rapidly evolving field?
Applying Epidemiology to Program Design for Chronic Disease Roughly 28.5 million Americans were still uninsured
Applying Epidemiology to Program Design for Chronic Disease Roughly 28.5 million Americans were still uninsured as of 2017, and 133 million Americans […] suffer from at least one chronic condition. —Nash et al. (2021, p. 5) As you know, promoting positive social change is a part of the Walden mission.